Viridian Therapeutics's market cap is currently $1.49B. The company's EPS TTM is $-4.312; its P/E ratio is ―; Viridian Therapeutics is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 314.00K	$ 1.77M	$ 2.96M	$ 1.05M	$ 4.46M
Gross Profit	$ -1.01M	$ 1.02M	$ 2.34M	$ -27.25M	$ -28.33M
Operating Income	$ -254.45M	$ -134.30M	$ -79.73M	$ -110.38M	$ -41.98M
EBITDA	$ -234.56M	$ -128.63M	$ -78.79M	$ -109.67M	$ -40.75M
Net Income	$ -237.73M	$ -125.44M	$ -79.42M	$ -110.98M	$ -42.42M
Balance Sheet
Cash & Short-Term Investments	$ 477.37M	$ 424.55M	$ 196.97M	$ 127.64M	$ 26.84M
Total Assets	$ 490.42M	$ 435.09M	$ 203.71M	$ 131.25M	$ 30.26M
Total Debt	$ 21.05M	$ 5.26M	$ 520.00K	$ 455.00K	$ 8.30M
Net Debt	$ -81.78M	$ -150.32M	$ -41.78M	$ -45.44M	$ -16.54M
Total Liabilities	$ 48.40M	$ 40.03M	$ 15.99M	$ 11.22M	$ 14.51M
Stockholders' Equity	$ 442.02M	$ 395.06M	$ 187.72M	$ 120.04M	$ 15.75M
Cash Flow
Free Cash Flow	$ -185.07M	$ -94.64M	$ -54.92M	$ -29.82M	$ -36.14M
Operating Cash Flow	$ -184.17M	$ -93.84M	$ -54.58M	$ -29.78M	$ -36.06M
Investing Cash Flow	$ -94.25M	$ -115.13M	$ -74.29M	$ -50.48M	$ 28.23M
Financing Cash Flow	$ 225.67M	$ 322.24M	$ 125.28M	$ 101.31M	$ 70.00K

Currency in USD

Viridian Therapeutics Earnings and Revenue History

Income Statement >

Viridian Therapeutics Debt to Assets

Balance Sheet >

Viridian Therapeutics Cash Flow

Cash Flow >

Viridian Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing